LY86 and Hypertension: In the present study, aldosterone‐infused WT mice developed HFpEF with LV hypertrophy, moderate hypertension, pulmonary congestion, and diastolic dysfunction while maintaining a preserved LVEF, and the above adverse effects were further exacerbated by MD1 deletion.